Nervonus en es it fr

Nervonus Brand names, Nervonus Analogs

Nervonus Brand Names Mixture

  • No information avaliable

Nervonus Chemical_Formula


Nervonus RX_link

No information avaliable

Nervonus fda sheet

Nervonus msds (material safety sheet)

Nervonus Synthesis Reference

No information avaliable

Nervonus Molecular Weight

309.469 g/mol

Nervonus Melting Point

< 25 oC

Nervonus H2O Solubility

Soluble as HCl salt

Nervonus State


Nervonus LogP


Nervonus Dosage Forms

Tablets (oral, 1 mg)

Nervonus Indication

Used for the symptomatic treatment of parkinsonism.

Nervonus Pharmacology

Metixene is a tertiary antimuscarinic with actions similar to those of atropine; it also has antihistaminic and direct antispasmodic properties. It is used for the symptomatic treatment of parkinsonism, including the alleviation of the extrapyramidal syndrome induced by other drugs such as phenothiazines, but, like other antimuscarinics, it is of no value against tardive dyskinesias. Metixene has been discontinued.

Nervonus Absorption

Absorbed in the gastrointestinal tract following oral administration, however the extent of absorption is not known.

Nervonus side effects and Toxicity

Signs of overdose include dilated and sluggish pupils, warm, dry skin, facial flushing, decreased secretions of the mouth, pharynx, nose, and bronchi, foul-smelling breath, elevated temperature, tachycardia, cardiac arrhythmias, decreased bowel sounds, urinary retention, delirium, disorientation, anxiety, hallucinations, illusions, confusion, incoherence, agitation, hyperactivity, ataxia, loss of memory, paranoia, combativeness, and seizures.

Nervonus Patient Information

Nervonus Organisms Affected

Humans and other mammals